Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04305756 · ClinicalTrials.gov registry record · NA
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
A NA study of Thrombosis and Thromboembolism, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT04305756 is a NA study of Thrombosis and Thromboembolism that has completed, run by University of Utah. The registered enrollment target is 146 participants, below the 465-participant average among 28 other Thrombosis trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04305756, a NA study of Thrombosis and Thromboembolism, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to evaluate the efficacy of two dosing regimens of low molecular weight heparin (LMWH) to reach prophylactic anti-factor Xa levels in post-cesarean delivery women. Half of participants will receive a fixed dose of LMWH, while the other half will receive a weight-based dose. The hypothesis is that the use of a weight-based dose will result in more women reaching prophylactic levels.
Conditions Studied
Interventions
- DRUG Enoxaparin
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2021-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04305756
The ClinicalTrials.gov registry entry for NCT04305756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 465-participant average among 28 other Thrombosis trials with a reported enrollment target (69% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Enoxaparin is the first listed.
NCT04305756 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT04305756 about?
NCT04305756 is a clinical study titled "Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery". The aim of this study is to evaluate the efficacy of two dosing regimens of low molecular weight heparin (LMWH) to reach prophylactic anti-factor Xa levels in post-cesarean delivery women. Half of participants will receive a fixed dose of LMWH, while the other half will receive a weight-based dose. ...
What is the current status of trial NCT04305756?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2020-06-12. Estimated completion is 2021-12-15.
What conditions does trial NCT04305756 study?
This clinical trial studies the following conditions: Thrombosis, Thromboembolism, Postpartum DVT.
What interventions are being tested in trial NCT04305756?
The interventions under investigation include: Enoxaparin (DRUG).
Who is sponsoring clinical trial NCT04305756?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04305756 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neonatal Platelet Transfusion Threshold Trial
RECRUITING · NA
-
PFA-100 Responsive to Effect of Energy Drinks on Platelet Function
COMPLETED · NA
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Vascular Lab Resource (VLR) Biorepository
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.